Geoffrey T. Nash

Geoffrey T. Nash

Auto-generated profile, based on publicly available information

Geoffrey T. Nash

Eli Lilly and Company

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2019 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
GLGuangxu Lan
Guangxu Lan
KNKaiyuan Ni
Kaiyuan Ni
SVSamuel S. Veroneau
Samuel S. Veroneau
XFXuanyu Feng
Xuanyu Feng
GNGeoffrey T. Nash
Geoffrey T. Nash
WLWenbin Lin
Wenbin Lin

18 August 2020 in Accounts of Chemical Research
Verified
Journal Article
Closed access
KNKaiyuan Ni
Kaiyuan Ni
TLTaokun Luo
Taokun Luo
GNGeoffrey T. Nash
Geoffrey T. Nash
WLWenbin Lin
Wenbin Lin

2 February 2021 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
GNGeoffrey T. Nash
Geoffrey T. Nash
TLTaokun Luo
Taokun Luo
GLGuangxu Lan
Guangxu Lan
KNKaiyuan Ni
Kaiyuan Ni
MKMichael Kaufmann
Michael Kaufmann
WLWenbin Lin
Wenbin Lin

24 September 2019 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
GLGuangxu Lan
Guangxu Lan
YQYangjian Quan
Yangjian Quan
MWMaolin Wang
Maolin Wang
GNGeoffrey T. Nash
Geoffrey T. Nash
EYEric You
Eric You
WLWenbin Lin
Wenbin Lin

25 September 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
DEDaniel A. Estabrook
Daniel A. Estabrook
LHLihua Huang
Lihua Huang
OLOlivia R. Lucchese
Olivia R. Lucchese
DCDylan J. Charland
Dylan J. Charland
ZYZhao Yu
Zhao Yu
TWTingting Wang
Tingting Wang
Lipid nanoparticles are a versatile class of clinically approved drug delivery vehicles, particularly for nucleic acid cargoes. Despite this, these materials often suffer from instability issues that limit shelf-life or necessitate storage at ultra-cold temperatures. Herein, we demonstrate that the oxidation of unsaturated hydrocarbons within ionizable lipid tails results in the production of a dienone species that changes the conformation of the lipid tail and generates an electrophilic degradant that reacts with neighboring siRNA cargoes to produce siRNA-lipid adducts. This mechanism highlights the interplay between lipid degradation, colloidal instability, RNA-lipid adduct formation, and loss of bioactivity. In this work, we show that revised drug product matrixes, including mildly acidic, histidine-containing formulations, can improve room temperature stability of siRNA-lipid nanoparticles by mitigating these oxidative degradation mechanisms.

12 June 2026 in ACS Nano
Verified
Journal Article
Open access
MZMeysam Mohammadi Zerankeshi
Meysam Mohammadi Zerankeshi
DCDylan J. Charland
Dylan J. Charland
KDKeira A. Donnelly
Keira A. Donnelly
GNGeoffrey T. Nash
Geoffrey T. Nash
JSJiale Shi
Jiale Shi
Alexander MarrasAlexander Marras
Alexander Marras
Messenger RNA (mRNA) lipid nanoparticles (mRNA-LNPs) are central to emerging vaccines and therapeutics, but their wide implementation is constrained by limited endosomal escape and instability during long-term storage and freezing. While buffers are routinely optimized to prevent instability, the impact of buffer on the internal structural organization of LNPs and, consequently, their delivery efficiency remain unresolved. Here, we study the impact of storage in Tris, histidine, and citrate buffers for mRNA-LNPs formulated with LP-01, MC3, and SM-102 ionizable lipids. We demonstrate that storage buffer identity and concentration govern mRNA-LNP internal ordering before and after freeze–thaw and are thus critical parameters for engineering high-performance formulations. Deconvoluting ordered phases into an mRNA-lipid region and excess lipid region reveals the importance of excess ionizable lipid behavior in enhancing endosomal escape. Prior to freezing, citrate buffer enhances transfection efficiency by promoting a transition to the fusogenic inverse hexagonal (HII) phase earlier during acidification, facilitated by a greater amount of ordered excess ionizable lipid. In contrast, Tris buffer provides the highest transfection efficiency after freeze–thaw by preventing aggregation and cargo loss while promoting favorable internal structure. Increasing Tris concentration from 10 to 50–150 mM leads to mRNA-rich bleb formation in freeze–thawed mRNA-LNPs, which improves freeze–thaw stability and thus transfection efficiency by mitigating mRNA-lipid adduct formation and accommodating a larger excess ionizable lipid region to facilitate HII phase formation. These findings establish a direct structural link between buffer conditions, particle size, internal morphology, and transfection efficiency, highlighting the importance of buffer composition in modulating mRNA-LNP performance.